Correction: challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience.

Where this comes from

• Record sourced from PubMed, PMID 25811784.
• Also identified by DOI 10.1371/journal.pone.0121162 and PMC identifier 4374716.
• No licence information is recorded for this record.
• Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.